Catalio, Tressa C.
HRN: 28-38-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/05/2026
02/11/2026
IV
2.5g
Q6
T/c Typhoid S/p Cs
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: